Novarex Coltd Stock Current Valuation

194700 Stock  KRW 7,380  90.00  1.23%   
Valuation analysis of NOVAREX CoLtd helps investors to measure NOVAREX CoLtd's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
7,380
Please note that NOVAREX CoLtd's price fluctuation is very steady at this time. Calculation of the real value of NOVAREX CoLtd is based on 3 months time horizon. Increasing NOVAREX CoLtd's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since NOVAREX CoLtd is currently traded on the exchange, buyers and sellers on that exchange determine the market value of NOVAREX Stock. However, NOVAREX CoLtd's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  7380.0 Real  6864.9 Hype  7380.0
The real value of NOVAREX Stock, also known as its intrinsic value, is the underlying worth of NOVAREX CoLtd Company, which is reflected in its stock price. It is based on NOVAREX CoLtd's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of NOVAREX CoLtd's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
6,865
Real Value
8,118
Upside
Estimating the potential upside or downside of NOVAREX CoLtd helps investors to forecast how NOVAREX stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of NOVAREX CoLtd more accurately as focusing exclusively on NOVAREX CoLtd's fundamentals will not take into account other important factors:
Hype
Prediction
LowEstimatedHigh
7,3767,3807,384
Details

NOVAREX CoLtd Company Current Valuation Analysis

NOVAREX CoLtd's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current NOVAREX CoLtd Current Valuation

    
  406.97 B  
Most of NOVAREX CoLtd's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NOVAREX CoLtd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition
In accordance with the recently published financial statements, NOVAREX CoLtd has a Current Valuation of 406.97 B. This is much higher than that of the sector and significantly higher than that of the Personal Products industry. The current valuation for all Republic of Korea stocks is notably lower than that of the firm.

NOVAREX Current Valuation Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NOVAREX CoLtd's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NOVAREX CoLtd could also be used in its relative valuation, which is a method of valuing NOVAREX CoLtd by comparing valuation metrics of similar companies.
NOVAREX CoLtd is rated third in current valuation category among its peers.

NOVAREX Fundamentals

About NOVAREX CoLtd Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze NOVAREX CoLtd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NOVAREX CoLtd using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NOVAREX CoLtd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Pair Trading with NOVAREX CoLtd

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NOVAREX CoLtd position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NOVAREX CoLtd will appreciate offsetting losses from the drop in the long position's value.

Moving together with NOVAREX Stock

  0.85226340 HMCIB SPAC 3PairCorr
  0.84293780 AptaBio TherapeuticsPairCorr
The ability to find closely correlated positions to NOVAREX CoLtd could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NOVAREX CoLtd when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NOVAREX CoLtd - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NOVAREX CoLtd to buy it.
The correlation of NOVAREX CoLtd is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NOVAREX CoLtd moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NOVAREX CoLtd moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NOVAREX CoLtd can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in NOVAREX Stock

NOVAREX CoLtd financial ratios help investors to determine whether NOVAREX Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NOVAREX with respect to the benefits of owning NOVAREX CoLtd security.